STAFF BOARD
Article
CHAIRMAN
Manuela Velázquez Prieto
EDITOR IN CHIEF
Jaime E. Poquet Jornet
MARKETING MANAGER
EDITORIAL BOARD
Tomás Casasín Edo
Virginia Hernández Corredoira
Ramón Jódar Masanés
Juan Carlos Juárez Giménez
Volume 21 - Issue 1, January-February 2019
SHORT REPORTS
THE CASE OF A HYPEROSMOLAR HYPERGLYCEMIC STATE INDUCED BY FUROSEMIDE IN A DIABETIC PATIENT
ALGAHTANI SAEED F, ALQAHTANI SALEH F, ALQAHTANI FAHAD M, QAHL MOHAMMED


Background: A Hyperosmolar Hyperglycaemic state (HHS) is one of the most serious acute metabolic emergencies in diabetic patients. In HHS, severe hyperglycaemia develops gradually over a period of days or weeks without remarkable ketone production; in other words, without ketosis or severe acidosis.

Case presentation: The patient is a 55-year-old male; he weighs 134 kg and his height is 192 cm. His body mass index (BMI) is 36.35 kg/m2. He is unable to work due to back problems and suffering from shortness of breath on exertion (SOBE). His blood glucose level was high (32.3 mmol/L), with an increase in urinary frequency.
He has type 2 diabetes mellitus, hypertension, and chronic kidney disease. HHS developed after using furosemide in modest doses for seven weeks.

Conclusion: Patients’ urine and blood glucose levels should be monitored at regular intervals in diabetic patients receiving furosemide as it may prompt the development of HHS in patients taking modest doses.

FUROSEMIDE - HYPERGLYCAEMIC - HYPEROSMOLAR



Fill out the form below to buy this article

Name and surname:

DNI/NIF ID/VAT IDENTIFICATION No.:

Contact Email:

Phone:

Address:

Zip code:

City:

Province:

Country:

*I have read and accept the privacy policy
Price : 30,25